SOURCE: IDenta Corp.

May 14, 2007 10:30 ET

International Drug & Explosives Detection Company IDenta Concludes U.S. Marketing Mission

HEATHROW, FL -- (MARKET WIRE) -- May 14, 2007 -- IDenta Corp. (PINKSHEETS: IDTA) today released a brief statement concerning the completion of its May marketing mission to the United States. During the two-week agenda, numerous meetings and product forums were conducted in Orlando, Atlanta, Los Angeles, and New York.

"This was by far the most productive mission we've had to the U.S. since IDenta initiated marketing efforts in the U.S. three years ago," asserted Yaacov Shoham, IDTA CEO. "I can now say with confidence that IDenta has developed a strong network of representatives in each state who have established relationships with law enforcement agencies on all levels -- local, state and federal. In addition, we made several important decisions concerning our investor relations communications program which, when finalized, we will be further detailing for our loyal shareholders."

Additional releases will be issued in the next two weeks with specific results of key meetings.

ABOUT IDENTA

Since becoming a public company in 2003, IDenta Corporation has become recognized as a world-wide leader in the development of proprietary on-site drug detection kits and most recently explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world. Information concerning IDenta's entire product line may be found at www.identa.biz.

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

Contact Information

  • Contact:
    For Investor Relations, lobbying interests or information
    concerning IDenta's products internationally contact:
    Yaacov Shoham
    IDenta Corp.
    CEO
    Tel: +972-52-6554487
    +972-8-9716874
    Fax: +972-8-9716875
    fpi@drugsdetector.com

    For Investor Relations in the United States contact:
    Randy Jacobs
    US Corporate Spokesman
    IDentaNews@sitcomllc.com
    1-800-316-9437